☆ 4.7 Article

Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation

Chung-Yen Li et al.

Summary: This study explored the effects of three different nitric oxide-releasing compounds on tumor progression in immune-competent mouse models and found that low doses of nitric oxide donors can inhibit tumor growth by regulating T cells and macrophages. Furthermore, low-dose nitric oxide donors may be combined with chemotherapeutic drugs in cancer therapy in the future.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

添加到收藏夹

Article Cell Biology

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

Wojciech Senkowski et al.

Summary: This article describes a method for culturing organoids from high-grade serous ovarian cancer (HGSC) with improved efficacy compared to previous reports (53% vs. 23%-38%). The organoids recapitulated genetic and phenotypic features of the original tumors. The organoid drug responses correlated with clinical treatment outcomes, but only in organoids maintained in human plasma-like medium. This resource facilitates the application of HGSC organoids in ovarian cancer research.

DEVELOPMENTAL CELL (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Liposomes in Cancer Therapy: How Did We Start and Where Are We Now

Melody D. D. Fulton et al.

Summary: Since their discovery in the 1960s, liposomes have been effective drug delivery systems for treating various cancers. However, their translation into the clinic has been incremental due to potential toxicity and lack of specific targeting. This review summarizes the properties of liposomes, their current status in cancer therapy, and the challenges they face.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Chemistry, Multidisciplinary

Cancer nanomedicine: a review of nano-therapeutics and challenges ahead

M. Joyce Nirmala et al.

Summary: Cancer is a dangerous disease with high mortality and limited treatment options. Nanomedicine offers a promising alternative due to its targeting capabilities and low toxicity. Various types of nanoparticles have been developed for cancer treatment and newer techniques involving extracellular vesicles and thermal nanomaterials are also being investigated. This review provides insights into the evolution, current status, and prospects of nanomedicine cancer studies.

RSC ADVANCES (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death

Chun-Yan Kong et al.

Summary: This review provides a comprehensive overview of the mechanisms underlying the oxidative stress and cell death pathways induced by doxorubicin, which are the major factors responsible for the acute cardiotoxicity. The authors aim to offer new insights for researchers to discover potential therapeutic strategies to prevent or reverse doxorubicin-induced cardiotoxicity.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications

Wee Han Poh et al.

Summary: The use of nitric oxide (NO) shows promise as a novel approach for treating antibiotic resistant bacteria and biofilm infections. Different strategies have been developed to overcome the limitations of NO's reactivity and enable controlled release, including the design of NO-releasing materials and encapsulation of NO donors. This review summarizes recent developments and discusses limitations and variability in biological responses to the use of NO for bacterial eradication.

MOLECULES (2022)

添加到收藏夹

Editorial Material Oncology

Exosomes in Cancer Therapy

Farrukh Aqil et al.

CANCERS (2022)

添加到收藏夹

Review Cell Biology

Exosomes as Drug Carriers in Anti-Cancer Therapy

Lan Chen et al.

Summary: Exosomes as potential drug carriers in cancer therapy have attracted a high demand, but their development still faces challenges. This article summarizes the current applications of exosomes derived from different cells as drug carriers in anti-cancer therapy in vitro and in vivo, and discusses the challenges and prospects of exosome-based drug delivery systems in cancer therapy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity

Antonio Gonzalez-Sarrias et al.

Summary: This study compared the delivery and anticancer activity of free curcumin and resveratrol with their encapsulation in milk-derived EXOs in breast tissue and breast cancer cell lines. The results demonstrated that milk EXOs enhanced the bioavailability and anticancer activity of curcumin and resveratrol, providing a promising approach for cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Oncology

Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application

Dulla Naveen Kumar et al.

Summary: Breast cancer is the second most common cancer globally, with treatment options including surgery, radiation, chemotherapy, and immunotherapy. Chemotherapy, while effective, is associated with various side effects, leading to the development of novel drug delivery systems such as exosomes. Exosomes, derived from biological fluids, serve as versatile platforms for drug delivery while bypassing traditional side effects.

CANCERS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Recent progress in nitric oxide-generating nanomedicine for cancer therapy

Yuce Li et al.

Summary: Nitric oxide (NO) is a versatile biological signaling molecule that has potential as an anticancer therapy. Targeted delivery of NO to tumors is necessary for better therapeutic effects.

JOURNAL OF CONTROLLED RELEASE (2022)

添加到收藏夹

Article Oncology

A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer

Nicole Anderle et al.

Summary: This study developed a new patient-derived tumor model for ovarian cancer, which consists of microtumors and tumor-infiltrating lymphocytes. The model successfully identified treatment-sensitive and treatment-resistant tumor models and can be used for personalized cancer treatments in the future.

CANCERS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Nitric Oxide-Releasing Platforms for Treating Cardiovascular Disease

Mingyue He et al.

Summary: Cardiovascular disease (CVD) is a leading cause of death worldwide. Nitric oxide (NO) plays an important role in the cardiovascular system and has been used for the treatment of CVD. Various biomaterial-based platforms have been developed to deliver NO in a controlled and sustained manner. Additionally, combining NO-releasing platforms with other therapeutic strategies can improve treatment effectiveness.

PHARMACEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery

Mohammad Feyzizadeh et al.

Summary: This review discusses various strategies to overcome multidrug resistance (MDR) in cancer therapy, including conventional synthetic and natural inhibitors, as well as novel approaches such as RNA, monoclonal antibodies, nanobiotechnology, and structural modification techniques. The experts emphasize the importance of understanding the structure of ABC transporters to design rational inhibitors and highlight the potential of herbal products in reversing MDR.

EXPERT OPINION ON DRUG DISCOVERY (2022)

添加到收藏夹

Review Immunology

Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics

Joel Mintz et al.

Summary: Nitric oxide (NO) is a signaling molecule that affects critical functions in the body and plays a bimodal role in carcinogenesis and tumor progression. There are conflicting findings regarding the effects of NO, but NO donors are the most well-studied and promising approach in NO-based anticancer therapies.

VACCINES (2021)

添加到收藏夹

Article Oncology

NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1-and ABCG2-Expressing Multidrug Human Cancer Cells

Birandra K. Sinha et al.

Summary: The development of resistance to chemotherapeutics in human cancers poses a serious problem in clinical practice. Overexpression of ABC efflux proteins on tumor cell membranes is believed to be a main mechanism for clinical resistance. Nitric oxide has shown promising potential in inhibiting ATPase functions of ABC transporters, leading to reversal of resistance to various anticancer drugs. Studies suggest that tumor-specific nitric oxide donors may be useful in treating human tumors overexpressing ABC transporters, including cancer stem cells.

CANCERS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol

Pooria Nakhaei et al.

Summary: Liposomes are a type of nanoparticles with a phospholipid membrane, rich in lipid contents, where cholesterol plays a vital role in stability. Despite various applications of liposomes, stability limitations still exist due to ingredient influence.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?

Joana C. Pieretti et al.

BIOCHEMICAL PHARMACOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Dr. NO and Mr. Toxic - the versatile role of nitric oxide

Constance Porrini et al.

BIOLOGICAL CHEMISTRY (2020)

添加到收藏夹

Article Oncology

A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia

Rupa Narayan et al.

CANCER (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs

Benjamin Bonavida

BIOCHEMICAL PHARMACOLOGY (2020)

添加到收藏夹

Review Oncology

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs

Mahendran Chinnappan et al.

CANCER LETTERS (2020)

添加到收藏夹

Article Oncology

Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma

Fumou Sun et al.

CANCER RESEARCH (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Reversal of drug resistance by JS-K and nitric oxide in ABCB1-and ABCG2-expressing multi-drug resistant human tumor cells

Birandra K. Sinha et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex

Loyanne C. B. Ramos et al.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Liposomal Drug Delivery Systems and Anticancer Drugs

Temidayo O. B. Olusanya et al.

MOLECULES (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells

Birandra K. Sinha et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)

添加到收藏夹

Review Oncology

Organoids in cancer research

Jarno Drost et al.

NATURE REVIEWS CANCER (2018)

添加到收藏夹

Review Oncology

Revisiting the role of ABC transporters in multidrug-resistant cancer

Robert W. Robey et al.

NATURE REVIEWS CANCER (2018)

添加到收藏夹

Article Chemistry, Medicinal

Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects

Zhangjian Huang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Anticancer potency of nitric oxide-releasing liposomes

Dakota J. Suchyta et al.

RSC ADVANCES (2017)

添加到收藏夹

Article Materials Science, Biomaterials

Controlled Release of Nitric Oxide from Liposomes

Dakota J. Suchyta et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)

添加到收藏夹

Article Materials Science, Biomaterials

Controlled Release of Nitric Oxide from Liposomes

Dakota J. Suchyta et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)

添加到收藏夹

Review Chemistry, Medicinal

Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives

Amedea B. Seabra et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Encapsulation of N-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery

Dakota J. Suchyta et al.

MOLECULAR PHARMACEUTICS (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Nitric oxide for cancer therapy

Sergio Huerta

FUTURE SCIENCE OA (2015)

添加到收藏夹

Review Oncology

3D tumor models: history, advances and future perspectives

Parul Benien et al.

FUTURE ONCOLOGY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment

Peter Kruzliak et al.

HEART FAILURE REVIEWS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Site-directed delivery of nitric oxide to cancers

Kavita Sharma et al.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2014)

添加到收藏夹

Review Oncology

The yin and yang of nitric oxide in cancer progression

Amy J. Burke et al.

CARCINOGENESIS (2013)

添加到收藏夹

Review Oncology

Nitric oxide and cancer: a review

Sheetal Korde Choudhari et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Biological activity of ruthenium nitrosyl complexes

Elia Tfouni et al.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2012)

添加到收藏夹

Review Pharmacology & Pharmacy

Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy

David Hirst et al.

CURRENT PHARMACEUTICAL DESIGN (2010)

添加到收藏夹

Article Oncology

The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents

Anna E. Maciag et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)

添加到收藏夹

Review Chemistry, Medicinal

Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery

Aura A. Eroy-Reveles et al.

FUTURE MEDICINAL CHEMISTRY (2009)

添加到收藏夹

Article Urology & Nephrology

Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer

D. Robert Siemens et al.

UROLOGY (2009)

添加到收藏夹

Review Urology & Nephrology

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

N. Pabla et al.

KIDNEY INTERNATIONAL (2008)

添加到收藏夹

Article Oncology

Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer

H Yasuda et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

添加到收藏夹

Review Biochemistry & Molecular Biology

Nitrosylation: The prototypic redox-based signaling mechanism

JS Stamler et al.

CELL (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.